Technology Antibody-Polymer Conjugates For Engaging T Cells To Destroy Cancer Cells An antibody linked to a polymer that connects T cells to cancer cells enabling broad cancer targeting and effective tumor cell killing without needing tumor-specific antigens The Unmet Need: Novel…
News Building a Platform to Fight Disease Chances are you’ve never heard of lymphangioleiomyomatosis, a rare lung disease that mostly affects women in their thirties and forties. With this disease, which is also called LAM, patients get...
Page Where Are They Now? Episode 7 Episode 7: Braintree May 27, 2021 Growing up in a small, religious town in Utah, Bryan Johnson felt he existed in a video game where the rules were all mapped...
News Drug Delivery, Diagnostics, AI Applications Among 10 Projects in the Spring 2021 I-Corps Cohort Ten teams are participating in the spring 2021 cohort of the Polsky I-Corps program – a highly experiential, 7-week-long program to empower scientists, researchers, and students to test the commercial...
News The Missing Piece: Epinoma Advances Novel Disease Detection Tech An early-stage biotechnology company, Epinoma, has licensed a DNA methylation analysis technology from the University of Chicago as part of its work developing novel tools for early cancer detection and...
News Midwest Biotech Startup Showcase Spotlights 30+ Breakthrough Innovations from Leading Research Institutions Bringing breakthrough science to the forefront of innovation, the Midwest Biotech Startup Showcase will highlight more than 30 emerging life sciences and biotech ventures from leading research institutions across the...
Technology Nucleic Acid Enrichment And Sequencing Method For Detecting Off-Target Base Editing Events Inrich-seq is a new method that selectively enriches and sequences inosine-containing DNA or RNA, enabling highly sensitive, genome-wide detection of off-target effects from adenine base editing in human cells The…
Technology Residual Bubble Control to Boost Ablative Ultrasound Efficacy Residual bubble clouds decrease the therapeutic efficacy of ablative ultrasound therapy. Ultrasound pulses can be used to destroy residual bubbles, however constructive interference limits simultaneous imaging and monitoring. The inventors…
Technology A Biomarker Analysis Platform For Predicting Immunotherapy Response And Survival In Cancer Patients A method using tumor sequencing data to measure membrane-localized neoantigens, helping predict which cancer patients will benefit from immunotherapy, even those with low tumor mutational burden, improving treatment selection and…
Technology Prolactin Receptor Antibodies For Targeted Cancer Therapy And Diagnosis Novel antibodies precisely targeting cancer cells by binding to the Prolactin Receptor (PRLR) to diagnose cancer, direct immune cells to destroy tumors, and inhibit cancer growth signals, without affecting healthy…